USPTO serial 79365664
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James R. Robinson
James R. Robinson Robinson Law Office, PLLC13 Loyola DriveHot Springs Village, AR 71909UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals, namely, proteins and other molecules for use in industry and science; proteins and other molecules used for manufacturing or as ingredients of foodstuffs for human and animal consumption, and food supplements for human and animal consumption; proteins and other molecules for use in medical research; proteins and other molecules used as industrial chemicals for manufacturing or as ingredients in cell culture media and diagnostic preparations; proteins and other biomolecules used for manufacturing or as ingredients of pharmaceuticals (biopharmaceuticals); enzymes and other molecules for industrial and scientific use; biological preparations for use in industry and science; cell growth media for growing cells and for use in scientific, biological and biotechnological research; biological preparations, namely, fats and lipids, proteins, peptides, living cells, living tissue, laboratory-grown living cells, laboratory-grown living tissue for use in industry and science | ACTIVE | — |
| 005 | Pharmaceutical and veterinary products; stem cells for medical, clinical, pharmaceutical and veterinary use; cell growth media for growing cells for medical, clinical, pharmaceutical and veterinary use; chemical preparations for medical, clinical, pharmaceutical and veterinary use; biological preparations for medical, clinical, pharmaceutical and veterinary use; bacterial preparations for medical, clinical, pharmaceutical and veterinary use; microbiological culture media for medical, clinical, pharmaceutical and veterinary use; enzyme preparations for medical, clinical, pharmaceutical and veterinary use; diagnostic preparations for medical, clinical, pharmaceutical and veterinary use; biological products in the nature of cell preparations for medical, clinical, pharmaceutical and veterinary use | ACTIVE | — |
| 010 | Apparatus for the regeneration of stem cells for medical use | ACTIVE | — |
| 029 | Meat, fish, poultry, game and synthetic substitutes; protein powder for use as a nutritional additive (food supplements) | ACTIVE | — |
| 042 | Chemical research; scientific research; biological research; chemical analysis; molecular research; genetic research; cell research | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 22, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 9, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 8, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 16, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 8, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 21, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 21, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 6, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 20, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 28, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 28, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 28, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 28, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 21, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 21, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 21, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 11, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Sep 15, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 14, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 24, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 23, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 23, 2023 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Jul 29, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 28, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 31, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 23, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |